Medtronic Inc. has launched something called the Guardian Real-time System for use by diabetics . The system is designed to monitor blood glucose levels amongst diabetics, and will be prescribed by doctors.
Described as a personal continuous glucose monitoring system (CGM), the system will incorporate Medtronic CareLink Personal Therapy Management Software. This integrates the data provided by the system and identifies patterns and trends to facilitate better glucose management.
The 20 million plus diabetics in American, not to mention the healthcare experts who treat them, should welcome the news . Managing blood glucose levels effectively lessens the chance of long-term complications developing, and could slash the overall cost of treatment.
Medtronic sell a number of insulin pumps, CGM systems, and diabetes management software products.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…